About Melanocyte-stimulating hormone receptor
Melanocyte-stimulating hormone receptor (MC1R) is a protein
from Homo sapiens identified by UniProt accession
Q01726, 317 residues long.
MolForge cross-references it against 0 known binders and
376 disease associations.
Target properties
| Protein name | Melanocyte-stimulating hormone receptor |
| UniProt accession | Q01726 |
| Gene | MC1R |
| Organism | Homo sapiens |
| Length | 317 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (4)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (376)
Diseases linked to this target (Open Targets).
- skin pigmentation · score 0.72
- hair colour measurement · score 0.66
- skin pigmentation measurement · score 0.57
- erythropoietic protoporphyria · score 0.53
- sun exposure measurement · score 0.51
- oculocutaneous albinism type 2 · score 0.49
- cutaneous melanoma · score 0.47
- hair color · score 0.45
- oculocutaneous albinism type 6 · score 0.43
- sunburn · score 0.43
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q01726-F1 | alphafold | PREDICTED | 80.51 | — |
Amino-acid sequence (317 residues)
MAVQGSQRRL LGSLNSTPTA IPQLGLAANQ TGARCLEVSI SDGLFLSLGL VSLVENALVV ATIAKNRNLH SPMYCFICCL ALSDLLVSGS NVLETAVILL LEAGALVARA AVLQQLDNVI DVITCSSMLS SLCFLGAIAV DRYISIFYAL RYHSIVTLPR ARRAVAAIWV ASVVFSTLFI AYYDHVAVLL CLVVFFLAML VLMAVLYVHM LARACQHAQG IARLHKRQRP VHQGFGLKGA VTLTILLGIF FLCWGPFFLH LTLIVLCPEH PTCGCIFKNF NLFLALIICN AIIDPLIYAF HSQELRRTLK EVLTCSW
Explore Melanocyte-stimulating hormone receptor with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets